Log In
Print
BCIQ
Print
Print this Print this
 

OTO-104

  Manage Alerts
Collapse Summary General Information
Company Otonomy Inc.
DescriptionSustained-release dexamethasone gel delivered via intratympanic injection
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase I
IndicationHearing loss
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today